XXXXXXXXX ROZHODNUTÍ XXXXXX (XX) 2020/528
xx xxx 14. dubna 2020,
xxxxxx xx xxxxxxxxx xxxxxxxxxx x Xxxxxxxx, Číně, Xxxxx Xxxxxx, Spojených xxxxxxx a Xxxxxxx xx xxxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxx pro xxxxxxxxx xxxxxxxxx xxxxxxxxxx xxxxx xxxxx xxxxxxxxx x xxx, koček x xxxxxx
(xxxxxxxx pod xxxxxx C(2020) 2103)
(Xxxx s xxxxxxxx xxx XXX)
XXXXXXXX XXXXXX,
x xxxxxxx na Xxxxxxx x xxxxxxxxx Xxxxxxxx xxxx,
x ohledem na xxxxxxxxxx Xxxx 2000/258/XX xx dne 20. xxxxxx 2000 x xxxxxx xxxxxxxxxx xxxxxxxxx xxxxxxxxxxx xx xxxxxxxxx xxxxxxxx xxxxxxxxxx pro xxxxxxxxxxx xxxxxxxxxxxxx xxxxx xxx sledování xxxxxxxxx xxxxxxxxxx látek xxxxx xxxxxxxxx&xxxx;(1), x xxxxxxx xx xx. 3 xxxx. 2 xxxxxxxxx xxxxxxxxxx,
xxxxxxxx x xxxxx xxxxxxx:
|
(1) |
Xxxxxxxxxx 2000/258/XX xxxxxx xxxxxxxxx Xxxxxx xxxxçxxxx xx sécurité sanitaire xxx xxxxxxxx (dále xxx „XXXXX“) xx xxxxxxxxxxxx Xxxxx xxxx xxxxxxxx xxxxxxxx xxxxxxxxx xx stanovení xxxxxxxx xxxxxxxxxx xxx normalizaci xxxxxxxxxxxxx xxxxx pro xxxxxxxxx xxxxxxxxx xxxxxxxxxx xxxxx proti xxxxxxxxx. XXXXX xxxx xxxx xxxxxxxxx xx Agence xxxxxxxxx xx sécurité xxxxxxxxx de x’xxxxxxxxxxxx, xx x’xxxxxxxxxxxxx et xx xxxxxxx (xxxx xxx „ANSES“) ve Xxxxxxx. |
|
(2) |
Xxxxxxxxxx 2000/258/ES xxxx xxxx xxxxxxx, že XXXXX hodnotí xxxxxxxxxx xx třetích zemích, xxxxx xxxxxxxxxx xxxxxx x xxxxxxxxx xx xxxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxx pro xxxxxxxxx xxxxxxxxx xxxxxxxxxx xxxxx xxxxx vzteklině. |
|
(3) |
Příslušný orgán x Xxxxxxxx xxxxxxxxx xxxxxx o xxxxxxxxx xxxxxxxxxx „Xxxxxx xx Xxxxxxxxx xx Raiva xx Xxxxxxxxxxx de Xxxxxxxxx Xxxxxxx x Xxxxxxxxx do Xxxxxxxxx xx Ciências Xxxxxxxxxx xx Xxxxxxxxxxxx xx Xãx Paulo“. ANSES xxx tuto xxxxxxxxx xxxxxxxxxxx příznivou xxxxxxxxx xxxxxx ze xxx 24. xxxxx 2019, xxxxxx předložila Xxxxxx. |
|
(4) |
Xxxxxxxxx xxxxx Xxxx xxxxxxxxx xxxxxx o xxxxxxxxx xxxx xxxxxxxxxx: „Xxxx Xxxx Xxxxx Biologicals Xxxxxxxxxxxxxx Xx., Xxx (Xxxxxx)“ a „Xxxxxx Xxxxxxx Xxxxxxxxxx Xxxxxx xx the Xxxxxxxxx xx Xxxxxx Xxxxxx xx the Xxxxxxxxx Xxxxxxx xx Agriculture Xxxxxxxx“. XXXXX xxx xxxx xxxxxxxxxx vypracovala xxxxxxxxx xxxxxxxxx xxxxxx xx dne 24. xxxxx 2019, xxxxxx xxxxxxxxxx Xxxxxx. |
|
(5) |
Xxxxxxxxx orgán Xxxx xxxxxxxxx xxxxxx x xxxxxxxx schválení xxxx laboratoří: „National Xxxxxxxxx Laboratory for Xxxxxx Rabies (Xxxxxxxxxx Xxxxxxxxxx xxx Xxxxxx xxx Xxxxxxxx Xxxxxxxxxx Xxxxxxxx)“ x „Xxxxxx xxx Xxxxxx Xxxxxxxx Xxxxx of xxx Xxxxxxxxxx xx Epidemiology xx xxx Xxxxxxxx Xxxxxxxxxx Xxxxxxxx Institute xx the Xxxxxxx xx Xxxxxxxx Xxxxxxx Xxxxxxxx“. XXXXX xxx xxxx xxxxxxxxxx xxxxxxxxxxx xxxxxxxxx hodnotící zprávu xx xxx 24. xxxxx 2019, kterou xxxxxxxxxx Komisi. |
|
(6) |
Příslušný xxxxx Xxxxx Koreje xxxxxxxxx xxxxxx x schválení xxxxxxxxxx „Rabies and Xxxxxxxx encephalitis XXX xxxxxxxxx xxxxxxxxxx xx Xxxxxx xxx Xxxxx Xxxxxxxxxx Xxxxxx“. ANSES xxx tuto xxxxxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxxx xxxxxx ze xxx 24. xxxxx 2019, xxxxxx předložila Xxxxxx. |
|
(7) |
Xxxxxxxxx xxxxx Xxxxxxx xxxxxxxxx xxxxxx x schválení xxxxxxxxxx „National Institute xx Xxxxxx Xxxxxx“. XXXXX pro tuto xxxxxxxxx vypracovala příznivou xxxxxxxxx zprávu ze xxx 24. října 2019, xxxxxx xxxxxxxxxx Xxxxxx. |
|
(8) |
Xxxxxxxxx xxxxx Xxxxxxxxx xxxxx xxxxxxxxx xxxxxx x xxxxxxxx schválení xxxxxxxxxx „Xxxxxxx for Xxxxxxx Xxxxxxx xxx Xxxxxxxxxx of the Xxxxxx Laboratory“. ANSES xxx tuto xxxxxxxxx xxxxxxxxxxx xxxxxxxxx xxxxxxxxx xxxxxx xx xxx 24. října 2019, xxxxxx xxxxxxxxxx Xxxxxx. |
|
(9) |
Xxxx xxxxxxxxxx by xxxxx xxxx xxx schváleny xx xxxxxx xxxxxxxxx xxxxxxxxxxxxx xxxxx pro xxxxxxxxx účinnosti xxxxxxxxxx xxxxx proti xxxxxxxxx x xxx, xxxxx x xxxxxx. |
|
(10) |
Xxxxxxxx xxxxxxxxx xxxxx rozhodnutím xxxx x xxxxxxx xx xxxxxxxxxxx Stálého xxxxxx xxx xxxxxxxx, xxxxxxx, xxxxxxxxx x xxxxxx, |
XXXXXXX XXXX XXXXXXXXXX:
Xxxxxx 1
X souladu x xx. 3 xxxx. 2 xxxxxxxxxx 2000/258/XX xx pro xxxxxxxxx xxxxxxxxxxxxx testů xx xxxxxx xxxxxxxxx xxxxxxxxx xxxxxxxxxx xxxxx xxxxx xxxxxxxxx x xxx, koček x xxxxxx schvalují tyto xxxxxxxxxx:
|
x) |
Xxxxxx de Xxxxxxxxx xx Raiva Xxxxxxxxxxx xx Xxxxxxxxx Xxxxxxx e Xxxxxxxxx do Xxxxxxxxx xx Xxêxxxxx Biomédicas Universidade xx Xãx Xxxxx Av. Xxxx. Lineu Xxxxxxx, 1374, xxxx 225 05508-000 Xãx Xxxxx Xxxxxxxx |
|
x) |
Xxxx Xxxx Xxxxx Biologicals Pharmaceutical Xx., Ltd (Xxxxxxx) 29 Xxxxxxxx Xxxx Road. Xxxxxxxxxx Xxxxxxxx Xxxx, Xxxxxx Xxxxxxxx, Xxxxxx Xxxx |
|
x) |
Xxxxxx Xxxxxxx Xxxxxxxxxx Center Institute xx Xxxxxx Xxxxxx, Guangdong Xxxxxxx of Xxxxxxxxxxx Xxxxxxxx 21 Xxxxxxxxxx Xxxxxx, Xxxxxx District Xxxxxxxxx, Xxxxxxxxx Xxxx |
|
x) |
Xxxxxxxx Xxxxxxxxx Laboratory xxx Xxxxxx Xxxxxx (Xxxxxxxxxx Xxxxxxxxxx xxx Xxxxxx xxx Wildlife Associated Xxxxxxxx) Xxxxxxxxx Xxxxxxxxxx Xxxxxxxx Xxxxxxxxx, Chinese Xxxxxxx xx Xxxxxxxxxxxx Xxxxxxxx 666 Xxxxxxx West Xxxx, Xxxxxxx Xxxxxxx Development Xxxxxxxx, Xxxxxxxxx, Xxxxx, Xxxx |
|
x) |
Centre xxx Xxxxxx Antibody Xxxxx, Xxxxxxxxxx xx Xxxxxxxxxxxx, Xxxxxxxx Xxxxxxxxxx Xxxxxxxx Xxxxxxxxx, Xxxxxxx xx Xxxxxxxx Xxxxxxx Xxxxxxxx 666 Xxxxxxx West Xxxx, Xxxxxxx Xxxxxxx Xxxxxxxxxxx Xxxxxxxx Xxxxxxxxx, Xxxxx Xxxx |
|
x) |
Xxxxxx xxx Xxxxxxxx xxxxxxxxxxxx XXX reference laboratory xx xxx Xxxxxx xxx Xxxxx Xxxxxxxxxx Xxxxxx 177 Hyeoksin 8-xx, Xxxxxxxx-xx, Xxxxxxxxxxxxx-xx, 39660, Xxxxx Xxxxx |
|
x) |
Xxxxxxx xxx Disease Xxxxxxx xxx Xxxxxxxxxx Xxxxxx Xxxxxxxxxx 1600 Clifton Xxxx, XX, Xxxxxxx, XX 30333, Xxxxxxx xxxxx xxxxxxxx |
|
h) |
Xxx Xxxxxxxx Institute xx Xxxxxx Xxxxxx 50/2 Xxxxxxxxxx, Xxxxxx, Chatuchak Xxxxxxx 10900 Thajsko |
Xxxxxx 2
Xxxx xxxxxxxxxx xx xxxxxx xxxxxxxx xxxxxx.
X Bruselu xxx 14. xxxxx 2020.
Xx Xxxxxx
Xxxxxx XXXXXXXXXX
xxxxxx Xxxxxx
(1) Úř. xxxx. X 79, 30.3.2000, s. 40.